[1]
“Treatment Response to Sorafenib in Liver Cancer; A Comprehensive Review on Association with Single Nucleotide Polymorphisms”, Precis. Med. Com., vol. 4, no. 2, pp. 85–114, Dec. 2024, doi: 10.55627/pmc.004.002.0555.